Results 271 to 280 of about 1,472,301 (348)

The IQGAP1-Claudin4-JNK Signaling Axis as a Differential Biomarker in Renal Cell Carcinoma. [PDF]

Clin Transl Sci
Puente N, Fan X, Nadiminty N, Ekwenna O, Petros FG, Sindhwani P, Gohara A, Yakirevich E, Osman MA.   +8 more
europepmc   +1 more source

N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential

iNew Medicine, EarlyView.
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen, Ru Ya, Ziling Zhang, Siyue Dong, Seol Hee Park, Wonhyo Seo, Yong He   +6 more
wiley   +1 more source

Renal-Type Clear Cell Carcinoma of the Prostate: A Histopathological Case Report of a Rare and Underrecognized Variant. [PDF]

Reports (MDPI)
Stoyanov G, Marchev D, Pavlov P, Popov H.   +3 more
europepmc   +1 more source

Napabucasin transforms liver microenvironment and boosts immunotherapy efficacy by converting potential metastases into “hot” tumors

Interdisciplinary Medicine, EarlyView.
Napabucasin reduces liver metastases by reprogramming the hepatic microenvironment. It induces hepatocyte secretion of CCL21 via c‐Fos activation, recruiting lymphocytes and converting “cold” metastases into immunologically “hot” tumors. This effect is liver‐specific and independent of cancer cells.
Qiongqiong Wang, Jiaqi Zhou, Hang Qiao, Yifan Jia, Ling Ye, Zeli Li, Jiahe Ouyang, Haoxian Zhou, Kangxin Zeng, Xuemeng Wang, Yixian Wang, Yang Zhang, Yupeng Zhang, Yizhou Cai, Yutao Hu, Minzhe Zhang, Wenwei Xu, Zhenzhen Wu, Xiaofang Qiu, Li Lin   +19 more
wiley   +1 more source

The Malignant Imposter: Cystic Renal Oncocytoma Challenging Bosniak Criteria. [PDF]

Cureus
N A, Suraj N, Anne D, Shetty B, R S.
europepmc   +1 more source

A summary of the status of de novo cancer in transplant recipients. [PDF]

, 1972
Penn, I, Starzl, TE
core  

Ultrasound–triggered tumor‐selective nitric oxide release enhances tumor penetration of antibody–conjugated nanomedicine

Interdisciplinary Medicine, EarlyView.
Ultrasound‐triggered nitric oxide release from S‐nitrosated hyaluronic acid (HA‐SNO) induces tumor vasodilation and disrupts the vascular barrier, potently enhancing the intratumoral penetration of antibody‐conjugated nanomedicines. Abstract The tumor vascular barrier restricts the penetration of antibody‐conjugated nanomedicine, severely limiting its ...
Xiaodong Wang, Ruifeng Duan, Xin Chen, Tongjun Liu, Zhilin Liu   +4 more
wiley   +1 more source

Incidental renal pelvis and ureteral verrucous carcinoma: A case report and literature review. [PDF]

Medicine (Baltimore)
Yang Z, Liu Y, Zhang X, Song L, Jiang J, Pan J, Li J, Li J.   +7 more
europepmc   +1 more source

Renal Clear Cell Carcinoma Discovered Following Pyothorax: A Case Report. [PDF]

Cureus
Benamou A, El Moudane A, Barki A.
europepmc   +1 more source